Conjuntivites

Texto completo disponível apenas em PDF.

• O Tema:
  “Conjuntivites”
  Desde as mais simples até as mais complexas, as conjuntivites são um achado freqüente nos consultórios, ambulatórios e pronto-socorros. O desenvolvimento de resistência bacteriana e o aparecimento de novas afecções, como a Febre Purpúrica Brasileira, mostram a importância e a necessidade desta revisão. Ainda, a manifestação da conjuntivite como primeiro sinal de uma doença sistêmica coloca o oftalmologista no importante papel de reconhecimento e tratamento precoce de tais doenças. São aqui discutidos os mais comuns e os novos agentes etiológicos conhecidos das conjuntivites, assim como as suas diferentes formas de apresentação clínica. Também apresenta-se uma revisão no diagnóstico e tratamento.

BIBLIOGRAFIA

• ¹
  JONES D., WILHELMUS K., MATOBA A., STEINKULLER P. IN American Academy of Ophthalmology; Anaheim, CA, 1991; pp2.
• ²
  LIMBERG M.: A review of bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol, 112:2, 1991.
• ³
  STEINERT R.: Current therapy for bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol, 112: 10, 1991.
• ⁴
  NEU H.: Microbiologic aspects of fluoroquinolones. Am J Ophthalmol, 4:26, 1991.
• ⁵
  PAVAN-LANGSTON D., DUNKEL E.: Antibiotic, Boston, Little, Brown, 1991.
• ⁶
  PAVAN-LANGSTON D.,FOULKS G.: Cornea and external disease. In D. Pavan-Langston (Ed.): Manual of ocular diagnosis and therapy, Boston, Little, Brown, 1991, 71.
• ⁷
  CDC: Preliminary report: epidemic fatal purpuric fever among children-Brazil. MMWR, 34:217, 1985.
• ⁸
  CDC: Brazilian purpuric fever: Haemophylus aegyptius bacteremia complicating purulent conjunctivitis. MMWR, 35:553, 1986.
• ⁹
  Brazilian Purpuric Fever Study Group: Brazilian purpuric fever: epidemic purpura fulminans associated with antecedent purulent conjunctivitis. Lancet, 757, 1987.
• ¹⁰
  Brazilian Purpuric Fever Study Group: Haemophylus aegyptius bacteraemia in brazilian purpuric fever. Lancet, 2:761, 1987.
• ¹¹
  BRENNER D., MAYER L., CARLONE G.: Biochemicha, genetic, and epidemiologic characterization of Haemophylus influenzae biogrup aegyptius (Haemophylus aegyptius) strains associated with Brazilian purpuric fever. J Clin Microbiol, 26: 1524, 1988.
• ¹²
  CDC: Brazilian Purpuric Fever-Mato Grosso, Brazil. MMWR, 39:903, 1990.
• ¹³
  HARRISON L., SILVA G., VRANJAC A., BROOME C., BRAZILIAN p. f. g.: Brazilian purpuric fever: an epidemiologic and clinical summary. Pediatr Infect Dis J, 8:239, 1989.
• ¹⁴
  LAGA M., NAAMARA W., BRUNHAM R., D'COSTA L., NSANZE H., PIOT P., KUNIMOTO D., NDINYA-ACHOLA J., SLANEY L., RONALD A., PLUMMER F.: Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl Med J, 315:1382, 1986.
• ¹⁵
  LEPAGE P., KESTELYN P., BOGAERTS J.: Treatment of gonococcal conjunctivitis with a single intramuscular injection of cefotaxime. J Antim Chemoth, 26:23, 1990.
• ¹⁶
  BARQUET N.; GASSER I., DOMINGO P., MORAGA F., MACAYA A., ELCUAZ R.: Primary meningococcal conjunctivitis: report of 21 patients andreview. Rev Infec Dis, 12:838, 1990.
• ¹⁷
  SMOLIN G.; The role of tears in the prevention of infections. Int Ophthalmol Clin, 27:25, 1987.
• ¹⁸
  FRANCIS I., LOUGHHEAD J.: Bell's phenomenon. A study of 508 patients. Aust J Ophthalmol, 12:15, 1984.
• ¹⁹
  DEAN D., STEPHENS R.: A rapid technique for evaluating the molecular epidemiology of trachoma in endemic regions by automated sequencing. Invest Ophthalmol Vis Sci, 32:985, 1991.
• ²⁰
  CAMPOS M., DOL S., O'BRIEN T., PRENDERGOST R., TAYLOR H., WHITTUN-HUDSON J.: OGP-MOMP as a vaccine against experimental trachoma. Ophthalmology, 95(S): 249, 1991.
• ²¹
  THYLEFORS B., DAWSON C., JONES B.: A simple system for the assessment of trachoma and its complications. Bull WHO, 65:477, 1987.
• ²²
  HIERHOLZER J., WIGAND R., ANDERSON L., ADRIAN T., GOLD J.: Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D(types 43-47). J Infect Dis, 158:804, 1988.
• ²³
  WIGAND R., ADRIAN T., BRICOUT F.: A new human adenovirus of subgenus D: candidate adenovirus type 42. Arch Virol, 94:283, 1987.
• ²⁴
  GORDON Y., ROMANOWSKI E., ARAULLO-CRUZ T.: Development of an animal model for ocular adenoviral infection. Invest Ophthalmol Vis Sci, 32:986, 1991.
• ²⁵
  NODA M., MIYAMOTO Y., IKEDA Y., MATSHUISHI T., OGINO T.: Intermediate human adenovirus type 22/H10, 19,37 as a new etiological agent of conjunctivitis. J Clin Microbiol, 29: 1286, 1991.
• ²⁶
  PAVAN-LANGSTON D.: Major ocular viral infections. In G. Galasso, R. Whitley and T. Merigan (Ed.): antiviral agents and viral diseases of man, New York, Raven Press, 1990,222.
• ²⁷
  MATOBA A.: Ocular disease associated with Epstein-Barr virus infection. Surv Ophthalmol, 35:145, 1990.
• ²⁸
  FRIEDLAENDER M.: Conjunctival provocative tests: a model of human ocular allergy. Tr Am Ophth Soc, 87:557, 1989.
• ²⁹
  LEONARDI A., FREGONA I., GISMONDI M., DANIOTTI E., CARNIEL G.,SECCHI A.: Correlation between conjunctival provocation test (CPT) and systemic allergometric tests in allergic conjunctivitis. Eye, 4:760, 1990.
• ³⁰
  ABELSON M., CHAMBERS W., SMITH L., Conjunctival allergen challenge. a clinical approach to studying allergic conjunctivitis. Arch Ophthalmol, 108:84, 1990.
• ³¹
  RODRIGUEZ R., SMITH L., GEORGE M., ABELSON M.: Recent advances in the therapy of ocular allergy. Ophthalmol cli Nor Am, 3:563, 1990.
• ³²
  ABELSON M., BUTRUS S., WESTON J.: Aspirin therapy in vernal conjunctivitis. Am J ophthalmol, 95:502, 1983.
• ³³
  MEYER E., KRAUS E., ZONIS S.: Efficacy of antiprostaglandin therapy in vernal conjunctivis. Br J Ophthallmol, 71:497, 1987.
• ³⁴
  ROTH G., STANFORD N., MAJERUS W.: Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA, 72:3073, 1975.
• ³⁵
  BENEZRA D., PE'ER J., BRODSKY M., COHEN E.: Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol, 101:278, 1986.
• ³⁶
  SECCHI A., TOGNON S., LEONARDI A.: Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol, 110:641, 1990.
• ³⁷
  TABBARA K., BLEIK J.: Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology, 98:1679, 1991.
• ³⁸
  NUSSENBLATT R., PALESTINE A.: Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol, 31: 159, 1986.
• ³⁹
  ANDERSON G., GROTH O.: Suppression of the allergic contact reaction in the guinea pig by ciclosporin. A. Int Arch Allergy Immunol, 78:396, 1985.
• ⁴⁰
  OKUDAIRA H., SAKURAI Y., TERADO K.: Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse. Int Arch Allergy Appl lmmunol, 79: 164, 1986.
• ⁴¹
  IRANI A., BUTRUS S., TABBARA K., SCHWARTZ L.: Distribution of MCtand MCtc in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol, 86:34, 1990.
• ⁴²
  GUPTA S., KHURANA A., AHLUWEALIA B., GUPTA N.: Topical indomethacin for vernal keratoconjunctivilis. Acta Ophthalmol, 69:95, 1991.
• ⁴³
  TUFT S,. KEMENY M., DART J., BUCKLEY R.: Clinical features of atopic ketaroconjunctivitis. Ophthalmology, 98;150, 1991.
• ⁴⁴
  FOSTER C., CALONGE M.: Atopic keratoconjunctivitis. Ophthalmology, 97:992, 1990.
• ⁴⁵
  BUCKLEY R., WRAY B., BELMAKER E.: Extreme hiperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics, 49:59, 1972.
• ⁴⁶
  FOSTER C., RICE B., DUTT J.: Immunopathology of atopic keratoconjunctivitis. Ophthalmology, 98: 1190, 1991.
• ⁴⁷
  DECHANT K., GOA K.: Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs, 41:202, 1991.
• ⁴⁸
  ASWAD M., TAUBER J., BAUM J.: Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis. Ophthalmology, 95:444, 1988.
• ⁴⁹
  ALLANSMITH M., KORB D., GREINER J.: Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol, 83:697, 1977.
• ⁵⁰
  SRINIVASAN B., JAKOBIEC F., IAMOTO T.: Giant papillary conjunctivitis with ocular prostheses. Arch Ophthalmol, 97:892, 1979.
• ⁵¹
  SUGAR A., MEYER R.: Giant papillary conjunctivitis after keratoplasty. Am J Ophthalmol, 91:239, 1981.
• ⁵²
  GREINER J.: Pappilary conjunctivitis induced by an epithelialized corneal foreign body. Ophthalmologica, 196:82, 1988.
• ⁵³
  CARLSON A., WILHELMUS K.: Giant papillary conjunctivitis associated with cyanoacrylate adhesive. Am J Ophthalmol, 104:434, 1987.
• ⁵⁴
  FRIEDLAENDER M.: Some unusual nonallergic causes of giant papillary conjunctivitis. Tr Am Opthalmol Soc, 88:341, 1990.
• ⁵⁵
  BALLOW M., DONSHIK P., RAPACZ P.: Immune responses in monkeys to lenses from patients with contact lens induced giant papillary conjunctivitis. CLAO J, 15:64, 1989.
• ⁵⁶
  DONSHIK P., EHLERS W.: The contact lens patient and ocular allergies. Int Ophthalmol Clin, 31:133, 1991.
• ⁵⁷
  HIDAYAT A., RIDDLE P.: Ligneous conjunctivitis. A clinicopathologic study of 17 cases. Ophthalmology, 94:949, 1987.
• ⁵⁸
  RUBIN A., BUCK D., MACDONALD M.: Ligneous conjunctivitis involving the cervix. Br J Obstet Gynaecol, 96: 1228, 1989.
• ⁵⁹
  BATEMAN J., PETTIT T., ISENBERG S., SIMONS K.: Ligneous conjunctivitis: an autosomal recessive disorder. J Ped Ophthalmol Strab, 23: 137, 1986.
• ⁶⁰
  EAGLE R., BROOKS J., KATOWITZ J., WEIMBERG J., PERRY H.: Fibrin as a major constituent of ligneous conjunctivitis. Am J Ophthalmol, 101:493, 1986.
• ⁶¹
  HOLLAND E., CHAN C., KUWABARA T., PALESTINE A., ROWSEY J., NUSSENBLATT R.: Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol, 107:160, 1989.
• ⁶²
  RUBIN B., HOLLAND E., de SMET M., BELFORT J. R, NUSSENBLAT R.: Response of reactivated ligneous conjunctivitis to topical cyclosporine. Am J Ophthalmol, 112:95, 1991.
• ⁶³
  BROWNING D., PROIA A.: Ocular rosásea. Surv Ophthalmol, 31: 145, 1986.
• ⁶⁴
  RUFLI T., BÜCHNER S.: T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatológica, 169: 1, 1984.
• ⁶⁵
  HOANG-XUAN T., RODRIGUEZ A., ZALTAS M., RICE B., FOSTER C.: Ocular rosacea. A histologic and immunopathologic study. Ophthalmology, 97:1468, 1990.
• ⁶⁶
  SCHMID G.: The global distribution of lyme disease. Rev Infect Dis, 7:41, 1985.
• ⁶⁷
  STEERE A.: Lyme disease. N Engl J Med, 321:586, 1989.
• ⁶⁸
  STEERE A., BARTENHAGEN N., CRAFT J., HUTCHINSON G., NEWMAN J., RAHN D., SIGAL L., SPIELER P., STENN K., MALAWISTA S.: The early clincal manifestations of lyme disease. Ann Int Med, 99: 76, 1983.
• ⁶⁹
  BRUHN F.: Lyme disease. Am J Dis Child, 138: 467, 1984.
• ⁷⁰
  AABERG T.: The expanding ophthalmologic spectrum of Lyme disease. Am J Ophthalmol, 107: 77, 1989.
• ⁷¹
  FLACH A., LAVOIE P.: Episcleritis, conjunctivitis, and keratitis as ocular manifestations of lyme disease. Ophthalmology, 97, 973, 1990.
• ⁷²
  WINTERKORN J.: Lyme disease: neurologic and ophthalmic manifestations. Surv Ophthalmol, 35: 191, 1990.
• ⁷³
  MOMBAERTS I., MAUDGAL P., KNOCKAERT D.: Bilateral follicular conjunctivitis as a manifestation of lyme disease. Am J Ophthalmol, 112: 96, 1991.
• ⁷⁴
  FRIDBERG D., STENSON S., ORENSTEIN J., TIERNO P., CHARLES N.: Microsporidial keratoconjunctivitis in acquired immunodeficiency syndrome. Arch Ophthalmol, 108; 504, 1990.
• ⁷⁵
  LOWDER C., MEISLER D., McMAHON J.: Microsporidia infection of the cornea in a man seropositive for human immunodeficiency virus. Am J Ophthalmol, 109: 242, 1990.
• ⁷⁶
  YEE R., TIO F., MARTINEZ J., HELD K., SHADDUCK J., DIDIER E.: Resolution of microsporidial epithelial keratopathy in a patient with AIDS. Ophthalmology, 98; 106, 1991.
• ⁷⁷
  SHADDUCK J.: Human microsporidiosis and AIDS. Rev Infect Dis, 11:203, 1989.
• ⁷⁸
  LUCCA J., FARRIS L., BIELORY L., CAPUTO A.: Keratoconjunctivitis sicca in male patients infected with human immudeficiency virus type 1. Ophthalmology, 97:1008, 1990.
• ⁷⁹
  SAMPLE S., CHERNOFF D., LENAHAN G., SERWONSKA M., RANGI S., SHERMAN J., SOOY C., HOLLANDER H., GOETZL E.: Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals. J Allergy Clin Immunol, 86:876, 1990.
• ⁸⁰
  KAWASAKI T., KOSAKI F., OKAWA S.: A new infantile acute febrile mucocutaneous lymph node syndrome. Pediatrics, 54:271, 1974.
• ⁸¹
  KATO H., KOIKE S., YAMAMOTO M.: Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr, 86:892, 1975.
• ⁸²
  SMITH L., NEWBURGER J., BURNS J.: Kawasaki syndrome and the eye. Pediatr Infect Dis J, 8:116, 1989.
• ⁸³
  WAKEFIELD D., PENNY R.: Cell-mediated immune response to chlamydia in anterior uveitis: role of HLA-B27. Clin Exp Immunol, 51:191, 1983.
• ⁸⁴
  WAKEFIELD D., MONTANARO A., CLUSKEY P.: Acute anterior uveitis and HLA-B27 Surv Ophthalmol, 36:223, 1991.
• ⁸⁵
  THEODORE J., LEIBOWITZ H.: External ocular toxicity of dipivalyl epinephrine. Am J Ophthalmol, 88:1013, 1979.
• ⁸⁶
  WILKERSON M., LEWIS R., SHIELDS M.: Follicular conjunctivitis associated with apraclonidine. Am J Ophthalmol, 111:105, 1991.

Datas de Publicação

• Publicação nesta coleção
  Sep-Oct 1992